Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoking cessation in heavy middle-aged smokers using e-cigarettes vs varenicline
2017-003188-36Phase 4Completed
- Sponsor
- Lapland Central Hospital
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of varenicline in nicotine dependence (2 arms), sponsored by Lapland Central Hospital. Primary endpoint: 24-week smoking abstinence rate. Started Nov 2017; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2017-003188-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003188-36.